ATORVASTATIN MYLAN

40MG TBL FLM 30

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 18.09.2020
Interruption of marketing 13.07.2020 0138125, 0145808, 0200829, 0200836, 0204690, 0204694, 0087018, 0087051, 0093019, 0093021
Manufacturing reasons 30.09.2020
Placing on the market 04.10.2019

All reports are available in the Overview.

Back to list